Living Cell‐Derived Intelligent Nanobots for Precision Oncotherapy

L Zhou, K Li, Y Liu, R Zhang, Y Yao… - Advanced Functional …, 2024 - Wiley Online Library
The progress of precision oncology medicine is always limited by the tumor off‐targeting, the
drug side effects, and the treatment inefficiency due to the complex and ever‐changing …

[HTML][HTML] Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications

S Salek-Ardakani, DM Zajonc, M Croft - Frontiers in Immunology, 2023 - frontiersin.org
Costimulatory receptors on immune cells represent attractive targets for immunotherapy
given that these molecules can increase the frequency of individual protective immune cell …

Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells

Y Zhou, J Jadlowsky, C Baiduc, AW Klattenhoff… - PLoS …, 2023 - journals.plos.org
Engineered T cells hold great promise to become part of an effective HIV cure strategy, but it
is currently unclear how best to redirect T cells to target HIV. To gain insight, we generated …

Myeloid Cell‐Triggered in Situ Cell Engineering for Robust Vaccine‐Based Cancer Treatment

WH Li, JY Su, BD Zhang, L Zhao, SH Zhuo… - Advanced …, 2024 - Wiley Online Library
Following the success of dendritic cell (DC) vaccine, cell‐based tumor vaccine shows its
promise as a vaccination strategy. Except for DC cells, targeting other immune cells …

Development of a Stable Peptide–Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry

SC Uslu, UJ Lee, S Tavakolpour… - ACS Pharmacology & …, 2024 - ACS Publications
T cells play a crucial role in antitumor immune responses and the clearance of infected cells.
They identify their targets through the binding of T-cell receptors (TCRs) to peptide–major …

Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission

H Su, A Mueller, H Goldstein - Current Opinion in HIV and AIDS, 2024 - journals.lww.com
Current Opinion in HIV and AIDS Log in or Register Subscribe to journalSubscribe Get new
issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …

Generation of Anti-HIV CAR-T Cells for Preclinical Research

H Su, K Anthony-Gonda, RJ Orentas, B Dropulić… - HIV Protocols, 2024 - Springer
The inability of people living with HIV (PLWH) to eradicate human immunodeficiency virus
(HIV) infection is due in part to the inadequate HIV-specific cellular immune response. The …

Activation and differentiation of cognate T cells by a dextran‐based antigen‐presenting system for cancer immunotherapy

D Mahata, D Mukherjee, D Biswas… - European Journal of …, 2023 - Wiley Online Library
Immunotherapeutic modulation of antigen‐specific T‐cell responses instead of the whole
repertoire helps avoid immune‐related adverse events. We have developed an artificial …

Modeling and Remodeling the Cell: How Digital Twins and HCMV Can Elucidate the Complex Interactions of Viral Latency, Epigenetic Regulation, and Immune …

H McMahon-Cole, A Johnson, SS Aghamiri… - Current Clinical …, 2023 - Springer
Abstract Purpose of Review Human cytomegalovirus (HCMV), while asymptomatic in most,
causes significant complications during fetal development, following transplant or in …

[HTML][HTML] Humanized mouse models for preclinical evaluation of HIV cure strategies

S Fraker, B Atkinson, A Heredia - AIDS reviews, 2022 - ncbi.nlm.nih.gov
Although the world is currently focused on the COVID-19 pandemic, HIV/AIDS remains a
significant threat to public health. To date, the HIV/AIDS pandemic has claimed the lives of …